Thesis

67 Evolutions in rectal cancer MRI staging and risk stratification in the Netherlands 4 References 1. Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D; ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40. 2. National Comprehensive Cancer Network. Rectal cancer (version 1.2021) Available at: https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf Accessed April 20, 2021 3. Federatie Medische specialisten. Landelijke richtlijn colorectaal carcinoom (2019 update). Available at: https://richtlijnendatabase.nl/richtlijn/colorectaal_carcinoom_crc/startpagina_-_ crc.html Accessed April 20, 2021 4. National Institute for Health and Care Excellence. (2020). Colorectal cancer [NICE Guideline No. 151]. https://www.nice.org.uk/guidance/ng151 5. Jessup M.J, Goldberg R.M, Asare E.A. et al. CP. Colon and Rectum. In: Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. Eds. AJCC Cancer Staging Manual (8th edition). Springer, 2017: 251-273 6. Maas M, Lambregts DM, Lahaye MJ, Beets GL, Backes W, Vliegen RF, Osinga-de Jong M, Wildberger JE, Beets-Tan RG. T-staging of rectal cancer: accuracy of 3.0 Tesla MRI compared with 1.5 Tesla. Abdom Imaging 2012;37(3):475-81. 7. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001;16(5):298-304. 8. S.J. Cawthorn, S.M. Caffarey, C.I.M. Broughton, C.G. Marks, M. Chir, D.V. Parums, N.M. Gibbs, R.P. A’Hern, Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335(8697):1055-1059 9. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324(11):709-15. 10. Willett CG, Badizadegan K, Ancukiewicz M, Shellito PC. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum. 1999;42(2):167-73. 11. Pollheimer MJ, Kornprat P, Pollheimer VS, Lindtner RA, Schlemmer A, Rehak P, Langner C. Clinical significance of pT sub-classification in surgical pathology of colorectal cancer. Int J Colorectal Dis. 2010;25(2):187-96. 12. MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007;243(1):132-9. 13. Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I et al. MERCURY study group. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253(4):711-9. 14. Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 2018;28(4):1465-1475. 15. Lord AC, D’Souza N, Shaw A, Rokan Z, Moran B, Abulafi M, Rasheed S, Chandramohan A, Corr A, Chau I, Brown G. MRI-Diagnosed Tumor Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal Cancer. Ann Surg. 2020; Sep 15. doi: 10.1097/ SLA.0000000000004499. Epub ahead of print. PMID: 32941279. 16. Lahaye MJ, Engelen SM, Nelemans PJ, Beets GL, van de Velde CJH, van Engelshoven JMA, BeetsTan RGH. Imaging for -predicting the risk factors—the circumferential resection margin and nodal disease—of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR 2005;26(4):259–268.

RkJQdWJsaXNoZXIy MjY0ODMw